President Trump on Friday announced another deal with UK-based pharmaceutical company AstraZeneca to lower drug costs for Americans on Medicaid.
The drug manufacturer will now sell prescription drugs to patients at Most Favored Nations prices through TrumpRx.gov.
This comes after the President struck a deal with Pfizer to also provide Americans with heavily discounted prescription drugs at most-favored-nation prices.
Trump made the announcement on AstraZeneca in the Oval Office on Friday, where he touted his efforts to lower drug costs during his first term and announced Most Favored Nations pricing from “the largest pharmaceutical manufacturer in the United Kingdom.”
“I had it going very well in my first term, but we were interrupted by rigged elections, so I was unable to carry it forward,” the President noted.
Trump also highlighted AstraZeneca’s plans to build a new plant in Charlottesville, Virginia, where they broke ground on Thursday, investing $50 billion in U.S. manufactuting, he said. “It’s going to have 3,600 jobs just to begin with, and that’s going to be a fantastic plant,” Trump said.
Trump delivered remarks on the new deal and AstraZeneca’s manufacturing plans in America for nearly seven minutes before taking questions from the press. AstraZeneca CEO Pascal Soriot, Health and Human Services Secretary Robert F. Kennedy Jr, CMS Administrator, Mehmet Oz, FDA commissioner Marty McCary, and Virginia Governor Glenn Youngkin joined the President and delivered remarks.
Hellbound and Down 